Similar articles

• Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases.

  Piessens WF, Schur PH, Moloney WC, Churchill WH. Piessens WF, et al. N Engl J Med. 1973 Jan 25;288(4):176-80. doi: 10.1056/NEJM197301252880403. N Engl J Med. 1973. PMID: 4629847 No abstract available.
• Quantitative analysis of IgG, IgA and IgM immunoglobulins in lymphatic leukemia and lymphosarcoma.

  Lawkowicz W, Kraj M, Cieśluk S. Lawkowicz W, et al. Arch Immunol Ther Exp (Warsz). 1972;20(2):227-34. Arch Immunol Ther Exp (Warsz). 1972. PMID: 4623511 No abstract available.
• Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia.

  Hsu CC, Marti GE, Schrek R, Williams RC Jr. Hsu CC, et al. Clin Immunol Immunopathol. 1975 Jan;3(3):385-95. doi: 10.1016/0090-1229(75)90026-4. Clin Immunol Immunopathol. 1975. PMID: 803233 No abstract available.
• [Membrane immunoglobulins on the surface of normal lymphocytes].

  Renoux M, Weill B. Renoux M, et al. Nouv Presse Med. 1973 Feb 3;2(5):283-8. Nouv Presse Med. 1973. PMID: 4119660 Review. French. No abstract available.
• B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.

  Seligmann M, Preud'Homme JL, Brouet JC. Seligmann M, et al. Transplant Rev. 1973;16:85-113. doi: 10.1111/j.1600-065x.1973.tb00118.x. Transplant Rev. 1973. PMID: 4204588 Review. No abstract available.